The DX27 monoclonal antibody specifically binds to CD158b, a 50–58 kDa type I glycoprotein also known as GLI83, p50.2, and p58.2. CD158b is expressed on natural killer cells and a rare subset of T cells. CD158b is composed of two extracellular Ig-like domains. The interaction of CD158b with specific HLA-C antigens on the surface of a target cell has been reported to inhibit cytotoxicity and limit cell lysis.
Anti-Human CD158b (DX27)-173Yb—100 Tests